Arrowstreet Capital, Limited Partnership Mannkind Corp Transaction History
Arrowstreet Capital, Limited Partnership
- $136 Billion
- Q2 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Mannkind Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,099,227 shares of MNKD stock, worth $4.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,099,227
Previous 2,716,429
59.53%
Holding current value
$4.02 Million
Previous $13.7 Million
69.91%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding MNKD
# of Institutions
247Shares Held
161MCall Options Held
1.24MPut Options Held
183K-
Black Rock Inc. New York, NY22.6MShares$82.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$66.5 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$39.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$27.9 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY7.01MShares$25.7 Million4.77% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $942M
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...